TSRX | Trius Therapeutics | Profile | Summary
TSRX | Trius Therapeutics | Profile | Summary
Trius Therapeutics, TSRX, has just raised $50 Million Dollars. The interesting thing about the company's IPO was, the size and the price of the offering was cut down almost in half before the IPO, thus providing an excellent opportunity and a little cushion for those who buy the stock in the open market.
We believe this could be a good opportunity for investors with long term horizon and risk tolerance. Remember after all it is developing a drug that has not been approved by the FDA yet. We also like to point out that it is suitable only for investors with high degree of risk tolerance and who are not looking for a quick pop.
TSRX is developing life-threatening bacterial infections like the antibiotic-resistant strains of staph infections, known as MRSA. The company says its drug is more potent and can be easily administered than what is currently being offered . In addition it is currently conducting two preclinical programs using its proprietary discovery platform to develop antibiotics to treat infections caused by bacteria of the gram-negative and gram-positive categories.
Source: The Company, OxBridgeResearch, PennyStockMonster, OTCking
Category: MRSA, Staph infection, IPO, Bio Pharma, Bio Thech.
A20100805
AMCF | Andatee China Marine Fuel | Profile | Summary
AMCF | Andatee China Marine Fuel | Profile | Summary
Andatee China Marine Fuel, AMCF, is engaged in the production, distribution of blended marine fuel oil for cargo and fishing vessels. The company own a large fuel storage facility and several oil depots. It also provides custom blended fuels to its clients.
The company has recently acquired a majority stake in Hailong Petrochemical Company, that would help increase the already rapidly growing distribution network.
The stock is slowly trending up from its June lows. The trade dominated Chinese economy and the company's geographical location (Dalian) certainly looks very appealing. Keep this company on your watch list.
source : The Company, OxBridgeResearch, PennyStockMonster, OTCking
category: Oil and Gas, Chinese stocks, growth stocks
A20100804
MRV Communications | MRVC | Profile | Summary
MRV Communications | MRVC | Profile | Summary
IT related corporate expenditure has seen a huge jump in the last quarter. Optical Equipment and Network Equipment related investment from the telecommunication companies is on the rise.
MRV Communications, MRVC, is in a great position to benefit this trend. The company is expected to report its quarterly earnings next week. We would like you to have this company on your watch list.
source: The Company, OxBridgeResearch, PennyStockMonster, OTCking
category: Network Equipment, Optical Equipment, Penny Stocks
A20100803
YRC Worldwide | YRCW | Profile | Summary
YRC Worldwide | YRCW | Profile | Summary
The economic turnaround has been painfully slow and that has not been very good to companies like YRC Worldwide, YRCW. However, We believe the economic activity will pick up for the rest of the year and YRCW is poised to benefit from the increased economic activity.
The stock is slowly bouncing back from its 52 wk lows on improved business outlook. You may see a little pull back to retest the lows that could provide a great opportunity for the investors who are looking for value and growth. If you are optimistic about the economy this stock should be on your list.
source: The Company, OxBridgeResearch, PennyStockMonster, OTCking
category: transport, shipping, penny stock, growth stock
Penny Stock Monster
Feed Entries
